Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 5

Global and United States Totally Implantable Intravenous Device (TIVAD) Market Report & Forecast 2022-2028

Global and United States Totally Implantable Intravenous Device (TIVAD) Market Report & Forecast 2022-2028

Industry: Medical Devices & Consumables

Published: 2022-04-23

Pages: 116 Pages

Report ld: 352028

  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
The totally implantable venous access deviceis a blood vessel or thoracoabdominal access device that is completely implanted in the body, which can reduce the pain and risk of repeated vein, artery, thoracoabdominal puncture.

Market Analysis and Insights: Global and United States Totally Implantable Intravenous Device (TIVAD) Market
This report focuses on global and United States Totally Implantable Intravenous Device (TIVAD) market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Totally Implantable Intravenous Device (TIVAD) market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Titanium Port Body accounting for % of the Totally Implantable Intravenous Device (TIVAD) global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Cancer was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Totally Implantable Intravenous Device (TIVAD) market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Totally Implantable Intravenous Device (TIVAD) Scope and Market Size
Totally Implantable Intravenous Device (TIVAD) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Totally Implantable Intravenous Device (TIVAD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Totally Implantable Intravenous Device (TIVAD) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Titanium Port Body
    Plastic Port Body

Segment by Application
    Cancer
    End-Stage Renal Disease
    Diabetes

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    C.R. Bard
    AngioDynamics
    Smiths Medical
    Bard Access Systems
    B. Braun
    Teleflex
    Cook Medical
    Fresenius Kabi
    PFM Medical
    Vygon
    Districlass
    PakuMed
    MedComp
    Navilyst Medical
    Norfolk Medical Products
    Suzhou Linhwa Medical Devices
    Weigao Holding
    Guangdong Baihe Medical Technology
 1 Study Coverage
1.1 Totally Implantable Intravenous Device (TIVAD) Product Introduction
1.2 Global Totally Implantable Intravenous Device (TIVAD) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Totally Implantable Intravenous Device (TIVAD) Sales in Volume for the Year 2017-2028
1.3 United States Totally Implantable Intravenous Device (TIVAD) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Totally Implantable Intravenous Device (TIVAD) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Totally Implantable Intravenous Device (TIVAD) Sales in Volume for the Year 2017-2028
1.4 Totally Implantable Intravenous Device (TIVAD) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Totally Implantable Intravenous Device (TIVAD) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Totally Implantable Intravenous Device (TIVAD) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Totally Implantable Intravenous Device (TIVAD) Market Dynamics
1.5.1 Totally Implantable Intravenous Device (TIVAD) Industry Trends
1.5.2 Totally Implantable Intravenous Device (TIVAD) Market Drivers
1.5.3 Totally Implantable Intravenous Device (TIVAD) Market Challenges
1.5.4 Totally Implantable Intravenous Device (TIVAD) Market Restraints
1.6 Study Objectives
1.7 Years Considered

 2 Market by Type
2.1 Totally Implantable Intravenous Device (TIVAD) Market Segment by Type
2.1.1 Titanium Port Body
2.1.2 Plastic Port Body
2.2 Global Totally Implantable Intravenous Device (TIVAD) Market Size by Type
2.2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Totally Implantable Intravenous Device (TIVAD) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Totally Implantable Intravenous Device (TIVAD) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Totally Implantable Intravenous Device (TIVAD) Market Size by Type
2.3.1 United States Totally Implantable Intravenous Device (TIVAD) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Totally Implantable Intravenous Device (TIVAD) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Totally Implantable Intravenous Device (TIVAD) Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
3.1 Totally Implantable Intravenous Device (TIVAD) Market Segment by Application
3.1.1 Cancer
3.1.2 End-Stage Renal Disease
3.1.3 Diabetes
3.2 Global Totally Implantable Intravenous Device (TIVAD) Market Size by Application
3.2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Totally Implantable Intravenous Device (TIVAD) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Totally Implantable Intravenous Device (TIVAD) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Totally Implantable Intravenous Device (TIVAD) Market Size by Application
3.3.1 United States Totally Implantable Intravenous Device (TIVAD) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Totally Implantable Intravenous Device (TIVAD) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Totally Implantable Intravenous Device (TIVAD) Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Totally Implantable Intravenous Device (TIVAD) Competitor Landscape by Company
4.1 Global Totally Implantable Intravenous Device (TIVAD) Market Size by Company
4.1.1 Top Global Totally Implantable Intravenous Device (TIVAD) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Manufacturer (2017-2022)
4.1.3 Global Totally Implantable Intravenous Device (TIVAD) Sales by Manufacturer (2017-2022)
4.1.4 Global Totally Implantable Intravenous Device (TIVAD) Price by Manufacturer (2017-2022)
4.2 Global Totally Implantable Intravenous Device (TIVAD) Concentration Ratio (CR)
4.2.1 Totally Implantable Intravenous Device (TIVAD) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Totally Implantable Intravenous Device (TIVAD) in 2021
4.2.3 Global Totally Implantable Intravenous Device (TIVAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Totally Implantable Intravenous Device (TIVAD) Manufacturing Base Distribution, Product Type
4.3.1 Global Totally Implantable Intravenous Device (TIVAD) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Totally Implantable Intravenous Device (TIVAD) Product Type
4.3.3 Date of International Manufacturers Enter into Totally Implantable Intravenous Device (TIVAD) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Totally Implantable Intravenous Device (TIVAD) Market Size by Company
4.5.1 Top Totally Implantable Intravenous Device (TIVAD) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Totally Implantable Intravenous Device (TIVAD) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Totally Implantable Intravenous Device (TIVAD) Sales by Players (2020, 2021 & 2022)

 5 Global Totally Implantable Intravenous Device (TIVAD) Market Size by Region
5.1 Global Totally Implantable Intravenous Device (TIVAD) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Totally Implantable Intravenous Device (TIVAD) Market Size in Volume by Region (2017-2028)
5.2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales in Volume by Region: 2017-2022
5.2.2 Global Totally Implantable Intravenous Device (TIVAD) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Totally Implantable Intravenous Device (TIVAD) Market Size in Value by Region (2017-2028)
5.3.1 Global Totally Implantable Intravenous Device (TIVAD) Sales in Value by Region: 2017-2022
5.3.2 Global Totally Implantable Intravenous Device (TIVAD) Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Totally Implantable Intravenous Device (TIVAD) Market Size YoY Growth 2017-2028
6.1.2 North America Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Totally Implantable Intravenous Device (TIVAD) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Totally Implantable Intravenous Device (TIVAD) Market Size YoY Growth 2017-2028
6.3.2 Europe Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Totally Implantable Intravenous Device (TIVAD) Market Size YoY Growth 2017-2028
6.4.2 Latin America Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE

 7 Company Profiles
7.1 C.R. Bard
7.1.1 C.R. Bard Corporation Information
7.1.2 C.R. Bard Description and Business Overview
7.1.3 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Products Offered
7.1.5 C.R. Bard Recent Development
7.2 AngioDynamics
7.2.1 AngioDynamics Corporation Information
7.2.2 AngioDynamics Description and Business Overview
7.2.3 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Products Offered
7.2.5 AngioDynamics Recent Development
7.3 Smiths Medical
7.3.1 Smiths Medical Corporation Information
7.3.2 Smiths Medical Description and Business Overview
7.3.3 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Products Offered
7.3.5 Smiths Medical Recent Development
7.4 Bard Access Systems
7.4.1 Bard Access Systems Corporation Information
7.4.2 Bard Access Systems Description and Business Overview
7.4.3 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Products Offered
7.4.5 Bard Access Systems Recent Development
7.5 B. Braun
7.5.1 B. Braun Corporation Information
7.5.2 B. Braun Description and Business Overview
7.5.3 B. Braun Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 B. Braun Totally Implantable Intravenous Device (TIVAD) Products Offered
7.5.5 B. Braun Recent Development
7.6 Teleflex
7.6.1 Teleflex Corporation Information
7.6.2 Teleflex Description and Business Overview
7.6.3 Teleflex Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Teleflex Totally Implantable Intravenous Device (TIVAD) Products Offered
7.6.5 Teleflex Recent Development
7.7 Cook Medical
7.7.1 Cook Medical Corporation Information
7.7.2 Cook Medical Description and Business Overview
7.7.3 Cook Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Cook Medical Totally Implantable Intravenous Device (TIVAD) Products Offered
7.7.5 Cook Medical Recent Development
7.8 Fresenius Kabi
7.8.1 Fresenius Kabi Corporation Information
7.8.2 Fresenius Kabi Description and Business Overview
7.8.3 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Products Offered
7.8.5 Fresenius Kabi Recent Development
7.9 PFM Medical
7.9.1 PFM Medical Corporation Information
7.9.2 PFM Medical Description and Business Overview
7.9.3 PFM Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 PFM Medical Totally Implantable Intravenous Device (TIVAD) Products Offered
7.9.5 PFM Medical Recent Development
7.10 Vygon
7.10.1 Vygon Corporation Information
7.10.2 Vygon Description and Business Overview
7.10.3 Vygon Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Vygon Totally Implantable Intravenous Device (TIVAD) Products Offered
7.10.5 Vygon Recent Development
7.11 Districlass
7.11.1 Districlass Corporation Information
7.11.2 Districlass Description and Business Overview
7.11.3 Districlass Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Districlass Totally Implantable Intravenous Device (TIVAD) Products Offered
7.11.5 Districlass Recent Development
7.12 PakuMed
7.12.1 PakuMed Corporation Information
7.12.2 PakuMed Description and Business Overview
7.12.3 PakuMed Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.12.4 PakuMed Products Offered
7.12.5 PakuMed Recent Development
7.13 MedComp
7.13.1 MedComp Corporation Information
7.13.2 MedComp Description and Business Overview
7.13.3 MedComp Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.13.4 MedComp Products Offered
7.13.5 MedComp Recent Development
7.14 Navilyst Medical
7.14.1 Navilyst Medical Corporation Information
7.14.2 Navilyst Medical Description and Business Overview
7.14.3 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Navilyst Medical Products Offered
7.14.5 Navilyst Medical Recent Development
7.15 Norfolk Medical Products
7.15.1 Norfolk Medical Products Corporation Information
7.15.2 Norfolk Medical Products Description and Business Overview
7.15.3 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Norfolk Medical Products Products Offered
7.15.5 Norfolk Medical Products Recent Development
7.16 Suzhou Linhwa Medical Devices
7.16.1 Suzhou Linhwa Medical Devices Corporation Information
7.16.2 Suzhou Linhwa Medical Devices Description and Business Overview
7.16.3 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Suzhou Linhwa Medical Devices Products Offered
7.16.5 Suzhou Linhwa Medical Devices Recent Development
7.17 Weigao Holding
7.17.1 Weigao Holding Corporation Information
7.17.2 Weigao Holding Description and Business Overview
7.17.3 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Weigao Holding Products Offered
7.17.5 Weigao Holding Recent Development
7.18 Guangdong Baihe Medical Technology
7.18.1 Guangdong Baihe Medical Technology Corporation Information
7.18.2 Guangdong Baihe Medical Technology Description and Business Overview
7.18.3 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Guangdong Baihe Medical Technology Products Offered
7.18.5 Guangdong Baihe Medical Technology Recent Development

 8 Industry Chain and Sales Channels Analysis
8.1 Totally Implantable Intravenous Device (TIVAD) Industry Chain Analysis
8.2 Totally Implantable Intravenous Device (TIVAD) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Totally Implantable Intravenous Device (TIVAD) Distributors
8.3 Totally Implantable Intravenous Device (TIVAD) Production Mode & Process
8.4 Totally Implantable Intravenous Device (TIVAD) Sales and Marketing
8.4.1 Totally Implantable Intravenous Device (TIVAD) Sales Channels
8.4.2 Totally Implantable Intravenous Device (TIVAD) Distributors
8.5 Totally Implantable Intravenous Device (TIVAD) Customers

 9 Research Findings and Conclusion

 10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Totally Implantable Intravenous Device (TIVAD) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Totally Implantable Intravenous Device (TIVAD) Market Trends
    Table 3. Totally Implantable Intravenous Device (TIVAD) Market Drivers
    Table 4. Totally Implantable Intravenous Device (TIVAD) Market Challenges
    Table 5. Totally Implantable Intravenous Device (TIVAD) Market Restraints
    Table 6. Global Totally Implantable Intravenous Device (TIVAD) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Totally Implantable Intravenous Device (TIVAD) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Totally Implantable Intravenous Device (TIVAD) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Totally Implantable Intravenous Device (TIVAD) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Totally Implantable Intravenous Device (TIVAD) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Totally Implantable Intravenous Device (TIVAD) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Totally Implantable Intravenous Device (TIVAD) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Totally Implantable Intravenous Device (TIVAD) Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Totally Implantable Intravenous Device (TIVAD) Sales Share by Manufacturer, 2017-2022
    Table 15. Global Totally Implantable Intravenous Device (TIVAD) Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Totally Implantable Intravenous Device (TIVAD) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Totally Implantable Intravenous Device (TIVAD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Totally Implantable Intravenous Device (TIVAD) as of 2021)
    Table 18. Top Players of Totally Implantable Intravenous Device (TIVAD) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Totally Implantable Intravenous Device (TIVAD) Product Type
    Table 20. Date of International Manufacturers Enter into Totally Implantable Intravenous Device (TIVAD) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Totally Implantable Intravenous Device (TIVAD) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Totally Implantable Intravenous Device (TIVAD) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Totally Implantable Intravenous Device (TIVAD) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Totally Implantable Intravenous Device (TIVAD) Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Totally Implantable Intravenous Device (TIVAD) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Totally Implantable Intravenous Device (TIVAD) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Totally Implantable Intravenous Device (TIVAD) Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Totally Implantable Intravenous Device (TIVAD) Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Totally Implantable Intravenous Device (TIVAD) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Totally Implantable Intravenous Device (TIVAD) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Totally Implantable Intravenous Device (TIVAD) Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Totally Implantable Intravenous Device (TIVAD) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Totally Implantable Intravenous Device (TIVAD) Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Totally Implantable Intravenous Device (TIVAD) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Totally Implantable Intravenous Device (TIVAD) Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Totally Implantable Intravenous Device (TIVAD) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. C.R. Bard Corporation Information
    Table 43. C.R. Bard Description and Business Overview
    Table 44. C.R. Bard Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. C.R. Bard Totally Implantable Intravenous Device (TIVAD) Product
    Table 46. C.R. Bard Recent Development
    Table 47. AngioDynamics Corporation Information
    Table 48. AngioDynamics Description and Business Overview
    Table 49. AngioDynamics Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. AngioDynamics Product
    Table 51. AngioDynamics Recent Development
    Table 52. Smiths Medical Corporation Information
    Table 53. Smiths Medical Description and Business Overview
    Table 54. Smiths Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Smiths Medical Product
    Table 56. Smiths Medical Recent Development
    Table 57. Bard Access Systems Corporation Information
    Table 58. Bard Access Systems Description and Business Overview
    Table 59. Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Bard Access Systems Product
    Table 61. Bard Access Systems Recent Development
    Table 62. B. Braun Corporation Information
    Table 63. B. Braun Description and Business Overview
    Table 64. B. Braun Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. B. Braun Product
    Table 66. B. Braun Recent Development
    Table 67. Teleflex Corporation Information
    Table 68. Teleflex Description and Business Overview
    Table 69. Teleflex Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Teleflex Product
    Table 71. Teleflex Recent Development
    Table 72. Cook Medical Corporation Information
    Table 73. Cook Medical Description and Business Overview
    Table 74. Cook Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Cook Medical Product
    Table 76. Cook Medical Recent Development
    Table 77. Fresenius Kabi Corporation Information
    Table 78. Fresenius Kabi Description and Business Overview
    Table 79. Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Fresenius Kabi Product
    Table 81. Fresenius Kabi Recent Development
    Table 82. PFM Medical Corporation Information
    Table 83. PFM Medical Description and Business Overview
    Table 84. PFM Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. PFM Medical Product
    Table 86. PFM Medical Recent Development
    Table 87. Vygon Corporation Information
    Table 88. Vygon Description and Business Overview
    Table 89. Vygon Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Vygon Product
    Table 91. Vygon Recent Development
    Table 92. Districlass Corporation Information
    Table 93. Districlass Description and Business Overview
    Table 94. Districlass Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Districlass Product
    Table 96. Districlass Recent Development
    Table 97. PakuMed Corporation Information
    Table 98. PakuMed Description and Business Overview
    Table 99. PakuMed Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. PakuMed Product
    Table 101. PakuMed Recent Development
    Table 102. MedComp Corporation Information
    Table 103. MedComp Description and Business Overview
    Table 104. MedComp Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. MedComp Product
    Table 106. MedComp Recent Development
    Table 107. Navilyst Medical Corporation Information
    Table 108. Navilyst Medical Description and Business Overview
    Table 109. Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Navilyst Medical Product
    Table 111. Navilyst Medical Recent Development
    Table 112. Norfolk Medical Products Corporation Information
    Table 113. Norfolk Medical Products Description and Business Overview
    Table 114. Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Norfolk Medical Products Product
    Table 116. Norfolk Medical Products Recent Development
    Table 117. Suzhou Linhwa Medical Devices Corporation Information
    Table 118. Suzhou Linhwa Medical Devices Description and Business Overview
    Table 119. Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. Suzhou Linhwa Medical Devices Product
    Table 121. Suzhou Linhwa Medical Devices Recent Development
    Table 122. Weigao Holding Corporation Information
    Table 123. Weigao Holding Description and Business Overview
    Table 124. Weigao Holding Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. Weigao Holding Product
    Table 126. Weigao Holding Recent Development
    Table 127. Guangdong Baihe Medical Technology Corporation Information
    Table 128. Guangdong Baihe Medical Technology Description and Business Overview
    Table 129. Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. Guangdong Baihe Medical Technology Product
    Table 131. Guangdong Baihe Medical Technology Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Totally Implantable Intravenous Device (TIVAD) Customers List
    Table 135. Totally Implantable Intravenous Device (TIVAD) Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Totally Implantable Intravenous Device (TIVAD) Product Picture
    Figure 2. Global Totally Implantable Intravenous Device (TIVAD) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Totally Implantable Intravenous Device (TIVAD) Market Size 2017-2028 (US$ Million)
    Figure 4. Global Totally Implantable Intravenous Device (TIVAD) Sales 2017-2028 (K Units)
    Figure 5. United States Totally Implantable Intravenous Device (TIVAD) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Totally Implantable Intravenous Device (TIVAD) Market Size 2017-2028 (US$ Million)
    Figure 7. United States Totally Implantable Intravenous Device (TIVAD) Sales 2017-2028 (K Units)
    Figure 8. United States Totally Implantable Intravenous Device (TIVAD) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Totally Implantable Intravenous Device (TIVAD) Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Totally Implantable Intravenous Device (TIVAD) Report Years Considered
    Figure 11. Product Picture of Titanium Port Body
    Figure 12. Product Picture of Plastic Port Body
    Figure 13. Global Totally Implantable Intravenous Device (TIVAD) Market Share by Type in 2022 & 2028
    Figure 14. Global Totally Implantable Intravenous Device (TIVAD) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Totally Implantable Intravenous Device (TIVAD) Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Totally Implantable Intravenous Device (TIVAD) Market Share by Type in 2022 & 2028
    Figure 20. United States Totally Implantable Intravenous Device (TIVAD) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Totally Implantable Intravenous Device (TIVAD) Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Totally Implantable Intravenous Device (TIVAD) Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Totally Implantable Intravenous Device (TIVAD) Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Cancer
    Figure 26. Product Picture of End-Stage Renal Disease
    Figure 27. Product Picture of Diabetes
    Figure 28. Global Totally Implantable Intravenous Device (TIVAD) Market Share by Application in 2022 & 2028
    Figure 29. Global Totally Implantable Intravenous Device (TIVAD) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Totally Implantable Intravenous Device (TIVAD) Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Totally Implantable Intravenous Device (TIVAD) Market Share by Application in 2022 & 2028
    Figure 35. United States Totally Implantable Intravenous Device (TIVAD) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Totally Implantable Intravenous Device (TIVAD) Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Totally Implantable Intravenous Device (TIVAD) Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Totally Implantable Intravenous Device (TIVAD) Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Totally Implantable Intravenous Device (TIVAD) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. United States Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Totally Implantable Intravenous Device (TIVAD) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Totally Implantable Intravenous Device (TIVAD) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. China Taiwan Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Totally Implantable Intravenous Device (TIVAD) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Colombia Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Totally Implantable Intravenous Device (TIVAD) Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Totally Implantable Intravenous Device (TIVAD) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Totally Implantable Intravenous Device (TIVAD) Value Chain
    Figure 74. Totally Implantable Intravenous Device (TIVAD) Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
The totally implantable venous access deviceis a blood vessel or thoracoabdominal access device that is completely implanted in the body, which can reduce the pain and risk of repeated vein, artery, thoracoabdominal puncture.

Market Analysis and Insights: Global and United States Totally Implantable Intravenous Device (TIVAD) Market
This report focuses on global and United States Totally Implantable Intravenous Device (TIVAD) market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Totally Implantable Intravenous Device (TIVAD) market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Titanium Port Body accounting for % of the Totally Implantable Intravenous Device (TIVAD) global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Cancer was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Totally Implantable Intravenous Device (TIVAD) market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Totally Implantable Intravenous Device (TIVAD) Scope and Market Size
Totally Implantable Intravenous Device (TIVAD) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Totally Implantable Intravenous Device (TIVAD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Totally Implantable Intravenous Device (TIVAD) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Titanium Port Body
    Plastic Port Body

Segment by Application
    Cancer
    End-Stage Renal Disease
    Diabetes

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    C.R. Bard
    AngioDynamics
    Smiths Medical
    Bard Access Systems
    B. Braun
    Teleflex
    Cook Medical
    Fresenius Kabi
    PFM Medical
    Vygon
    Districlass
    PakuMed
    MedComp
    Navilyst Medical
    Norfolk Medical Products
    Suzhou Linhwa Medical Devices
    Weigao Holding
    Guangdong Baihe Medical Technology
    
Global and United States Totally Implantable Intravenous Device (TIVAD) Market Report & Forecast 2022-2028

Industry: Medical Devices & Consumables

Published: 2022-04-23

Pages: 116 Pages

Report ld: 352028

CHOOSE LICENSE TYPE
提示

USD 4350.00

提示

USD 6525.00

提示

USD 8700.00

/uploads/payment/payIcon/masterCard-01.svg/uploads/payment/payIcon/american-express-01.svg/uploads/payment/payIcon/visa-01.svg/uploads/payment/payIcon/diners-club-01.svg/uploads/payment/payIcon/discover-4-01.svg/uploads/payment/payIcon/jcb-01.svg
加入购物车

Add to Cart

立即购买

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

加入购物车

Add to Cart

立即购买

Buy Now